Edesa Biotech (EDSA) Non Operating Income (2013 - 2026)

Edesa Biotech has reported Non Operating Income for 13 years, with the latest figure at $93714.0 in Q4 2025.

• Quarterly Non Operating Income fell 66.7% year-over-year to $93714.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $539121.0 (down 43.13% YoY) and the FY2025 annual result came in at $726843.0, down 14.03% from the prior year.
• Non Operating Income declined to $93714.0 in Q4 2025 per EDSA's latest filing, from $241890.0 in the prior quarter.
• Over five years, Non Operating Income peaked at $7.3 million in Q1 2021 and troughed at $6715.0 in Q1 2022.
• A 5-year average of $685032.8 and a median of $166628.5 in 2023 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2021 and 2022: Non Operating Income soared 49060.2% in 2021, then sank 99.91% in 2022.
• Over 5 years, Non Operating Income stood at $783046.0 in 2021, then sank by 94.45% to $43488.0 in 2022, then surged by 311.56% to $178978.0 in 2023, then surged by 57.25% to $281436.0 in 2024, then plunged by 66.7% to $93714.0 in 2025.
• According to Business Quant data, Non Operating Income over the past three periods registered $93714.0, $241890.0, and $154279.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.